- ￥291 - 4950
- MedChemExpress(MCE)
- 美国
- HY-10087
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件：
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名：
ABT-263
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
923564-51-6
- 规格：
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg/100 mg/200 mg
| 规格： | 10 mM * 1 mL | 产品价格： | ￥1029.0 |
|---|---|---|---|
| 规格： | 1 mg | 产品价格： | ￥291.0 |
| 规格： | 5 mg | 产品价格： | ￥650.0 |
| 规格： | 10 mg | 产品价格： | ￥960.0 |
| 规格： | 25 mg | 产品价格： | ￥1713.0 |
| 规格： | 50 mg | 产品价格： | ￥2500.0 |
| 规格： | 100 mg | 产品价格： | ￥3500.0 |
| 规格： | 200 mg | 产品价格： | ￥4950.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
Navitoclax
CAS No. : 923564-51-6
MCE 国际站：Navitoclax
产品活性：Navitoclax (ABT-263) 是一种口服有效的 Bcl-2 抑制剂，可与 Bcl-xL，Bcl-2，Bcl-w 等多种 Bcl-2 家族蛋白结合，Ki 值小于 1 nM。
研究领域：Apoptosis
作用靶点：Bcl-2 Family
In Vitro: Navitoclax (ABT-263) is active against approximately one-half of the cell lines of the PPTP in vitro panel. The median IC50 for all of the lines in the panel is 1.91 μM. Navitoclax in combination with chemotherapy agents leads most ovarian cancer cell lines a synergistic response, and enhances the caspase activation in both SK-OV-3 and IGROV-1 cell lines.
In Vivo: Navitoclax (100 mg/kg; orally; 21-day treatment) enhances the activity of OSI-744 in vivo. As a single agent, 100 mg/kg Navitoclax alone dosed daily has no significant antitumor activity, whereas daily dosing of OSI-744 at 50 mg/kg results in significant tumor stasis (%TGI=52) during a 21-day treatment period. Notably, the combination of Navitoclax and OSI-744 dosed daily for 21 consecutive days results in 98% TGI and durable tumor regressions in 100% of treated tumor-bearing mice.
相关产品：Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Anti-Cancer Compound Library | Clinical Compound Library | Peptidomimetic Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | Orally Active Compound Library | Anti-Blood Cancer Compound Library | Mitochondria-Targeted Compound Library | Targeted Diversity Library | Rare Diseases Drug Library | Protein-protein Interaction Inhibitor Library | Anti-Prostate Cancer Compound Library | Venetoclax | Polyinosinic-polycytidylic acid | S63845 | ABT-737 | A-1331852 | AZD-5991 | BT2 | Chlorin e6 | A-1155463 | MIK665 | Estradiol benzoate | BAI1 | Benzbromarone | Obatoclax Mesylate | Digitoxin | Chelerythrine chloride | BI-3802 | AZD4320 | Dehydrocorydaline | WEHI-539 hydrochloride | Tapotoclax | Amantadine | A-1210477 | Gambogic Acid | BTSA1 | Bax inhibitor peptide V5 | UMI-77 | Cardamonin | TCPOBOP | Daphnetin
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料
